No business likes bad debt, but it’s a common occurrence. In this article, we explore the revenue losses companies face when customers fail to pay.
YoY growth in Bad Debt
YoY growth in Accounts Receivable
average Bad Debt-to-Sales ratio in 2023
average Bad Debt-to-AR ratio in 2023
Imagine a thriving business, where sales are surging and customer relationships are strengthening through the flexibility of extended credit.
On paper, everything looks ideal. But beneath the surface, there's a slow, invisible drain: unpaid invoices that, with time, turn into bad debt.
For many companies, this isn’t just an occasional setback; it’s a recurring cost that grows quietly in the background, eroding profits and eating into cash flow.
As economic pressures mount, CFOs are left with a pressing question: How much is too much? And at what point does a calculated risk become a costly oversight?
For our analysis, we zeroed in on three powerhouse industries in the U.S.—Manufacturing, Healthcare, and Technology.
Our focus is on the top 50 revenue-generating companies from the Fortune 1000. To truly understand how bad debt chips away at their financial health, we dig deep into two critical metrics:
The bad debt-to-sales ratio reveals the percentage of a company's sales lost due to unpaid invoices, while the bad debt-to-accounts receivable ratio shows what percentage of accounts receivable is considered uncollectible.
The 2023 Bad Debt-to-Sales Ratio data shows significant disparities among companies:
The average ratio in 2023 was 1.49%, exceeding both high and low performer thresholds. This indicates that while some companies manage bad debt effectively, many grapple with higher ratios, potentially impacting their financial health and operations.
Although these percentages seem small, the actual dollar amounts are significant.
For example, if a company with $1 Billion in sales loses $10 millions in bad debt, that’s 1% in terms of bad debt-to-sales ratio. Reducing the bad debt ratio by another 0.01% could save another $100,000.
The analysis reveals significant disparities in how companies manage accounts receivables and bad debts.
Interestingly, the average ratio across all companies stood at 10.55%, which is considerably higher than both the high and low performer thresholds. This suggests that a subset of companies with extremely high ratios may be skewing the average upward.
Fortune 500’s AR, Treasury & Accounting tactics delivered monthly to your inbox.
We uncovered some interesting and potentially concerning trends in the company's financial performance from 2021 to 2023.
Over this three-year period, companies witnessed a Compound Annual Growth Rate (CAGR) of 7.49% in sales revenue, indicating healthy top-line growth. Accounts receivable grew at a slightly lower rate of 6.94%, which is generally positive as it suggests effective collection management relative to sales growth.
However, the most striking figure is the substantial 25.6% CAGR in bad debt. This disproportionate increase in bad debt, compared to the growth in sales and accounts receivable, raises significant concerns about the company's credit management practices and the financial health of its customer base.
These findings prompt us to examine industry-wide data.
Technology: The technology sector boomed during the pandemic, with a year-over-year (YoY) increase of 9.2% in receivables. The overall bad debt-to-sales ratio ranged from 0% to 1.38%. On average, this ratio increased by 0.02 percentage points in 2023 from the 2022 levels. Meanwhile, the bad debt-to-accounts receivable ratio rose by 0.15 percentage points to 2.28% in 2023, up from 2.13% in 2022.
Manufacturing: The manufacturing industry saw an 8.1% YoY increase in accounts receivable over three years. In 2023, the bad debt-to-sales ratio ranged between 0.07% and 1.37%. The industry average rose by 0.03 percentage points from 2022 levels of 0.39%. In the same year, the bad debt-to-accounts receivable ratio increased by 0.13 percentage points compared to the previous year.
Healthcare: The healthcare industry stood out as an outlier, with bad debt-to-sales ratios ranging widely from 0.25% to 55.49%, averaging 5.15% in 2023. The collection moratoriums issued by regulators had forced healthcare & life sciences businesses to temporarily suspend their collections during the pandemic years. This impacted their bad debt expenses and write-offs.
However, this figure has been trending downward; compared to 2022 levels, the ratio decreased by 0.4 percentage points in 2023. A similar trend emerged in the debt-to-accounts receivable ratio—it decreased from 38.13% to 37%, a drop of 1.13 percentage points from 2022 to 2023.
Here’s what the best performers consistently do to reduce their bad debt:
Proactive Collections: In addition to strong credit risk management, most companies have dedicated collection teams to follow up with customers and address grievances. They also offer self-service portals that allow customers to make payments, download invoices, and track credit limits.
As businesses face higher interest rates and tightening credit conditions, bad debt is poised to become an even bigger challenge. But with the right credit management and collection strategies, companies can minimize its impact.
To stay ahead, businesses should benchmark their bad debt ratios and continuously refine their credit policies. After all, in the game of business, it’s not just about growing fast—it’s about growing smart.
Want more insights? Subscribe to our finance newsletter for the latest in finance—from the best finance newsletters and compelling finance stories to treasury, R2R and AR insights.
Subscribe to the FINsider for real-time finance insights, stories, and industry trends.
Fortune 500’s AR, Treasury & Accounting tactics delivered monthly to your inbox.
On a scale of 0 to 10, how likely are you to recommend FINsider to a friend or colleague?
What can we improve on?
What did we do well?
Email for survey follow-up*
Thank You
For your Feedback!